JP2024010006A5 - - Google Patents

Download PDF

Info

Publication number
JP2024010006A5
JP2024010006A5 JP2023179480A JP2023179480A JP2024010006A5 JP 2024010006 A5 JP2024010006 A5 JP 2024010006A5 JP 2023179480 A JP2023179480 A JP 2023179480A JP 2023179480 A JP2023179480 A JP 2023179480A JP 2024010006 A5 JP2024010006 A5 JP 2024010006A5
Authority
JP
Japan
Prior art keywords
promoter
cells
medical
medicament according
inflammatory disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023179480A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024010006A (ja
Filing date
Publication date
Priority claimed from JP2020199368A external-priority patent/JP2021046416A/ja
Application filed filed Critical
Publication of JP2024010006A publication Critical patent/JP2024010006A/ja
Publication of JP2024010006A5 publication Critical patent/JP2024010006A5/ja
Pending legal-status Critical Current

Links

JP2023179480A 2015-01-08 2023-10-18 α1-アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞 Pending JP2024010006A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP15150454.5 2015-01-08
EP15150454 2015-01-08
EP15191934.7 2015-10-28
EP15191934 2015-10-28
JP2020199368A JP2021046416A (ja) 2015-01-08 2020-12-01 α1−アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞
JP2022166094A JP7374527B2 (ja) 2015-01-08 2022-10-17 α1-アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022166094A Division JP7374527B2 (ja) 2015-01-08 2022-10-17 α1-アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞

Publications (2)

Publication Number Publication Date
JP2024010006A JP2024010006A (ja) 2024-01-23
JP2024010006A5 true JP2024010006A5 (https=) 2024-02-27

Family

ID=55129837

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017536359A Pending JP2018502579A (ja) 2015-01-08 2016-01-08 α1−アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞
JP2020199368A Pending JP2021046416A (ja) 2015-01-08 2020-12-01 α1−アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞
JP2022166094A Active JP7374527B2 (ja) 2015-01-08 2022-10-17 α1-アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞
JP2023179480A Pending JP2024010006A (ja) 2015-01-08 2023-10-18 α1-アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2017536359A Pending JP2018502579A (ja) 2015-01-08 2016-01-08 α1−アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞
JP2020199368A Pending JP2021046416A (ja) 2015-01-08 2020-12-01 α1−アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞
JP2022166094A Active JP7374527B2 (ja) 2015-01-08 2022-10-17 α1-アンチトリプシン(AAT)を発現する遺伝子改変された間葉系幹細胞

Country Status (18)

Country Link
US (3) US20180000969A1 (https=)
EP (1) EP3242933B1 (https=)
JP (4) JP2018502579A (https=)
CN (1) CN107208063A (https=)
AU (1) AU2016206033B2 (https=)
CA (1) CA2970993C (https=)
CY (1) CY1122004T1 (https=)
DK (1) DK3242933T3 (https=)
ES (1) ES2727820T3 (https=)
HU (1) HUE043478T2 (https=)
IL (1) IL253063B (https=)
LT (1) LT3242933T (https=)
PL (1) PL3242933T3 (https=)
PT (1) PT3242933T (https=)
RS (1) RS58977B1 (https=)
SI (1) SI3242933T1 (https=)
SM (1) SMT201900381T1 (https=)
WO (1) WO2016110565A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210086662A (ko) * 2018-10-29 2021-07-08 오타와 하스피털 리서치 인스티튜트 Aoah를 과발현하는 유전자조작된 중간엽 줄기 세포 및 이의 용도
CN109512893A (zh) * 2018-11-05 2019-03-26 北京世纪劲得生物技术有限公司 间充质干细胞及其注射液和组合物在高尿酸血症中的应用
WO2021020509A1 (ja) * 2019-07-31 2021-02-04 株式会社ステムリム 間葉系幹細胞の増殖促進または減少抑制のための組成物
EP4585223A3 (en) * 2020-01-15 2025-07-30 The Regents of the University of California Transplanted cell protection via inhibition of polymorphonuclear cells
EP3964265A1 (en) * 2020-09-07 2022-03-09 Fundacion Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz Mesenchymal stem cells co-expressing cxcr4 and il-10 and uses thereof
EP4240323A1 (en) * 2020-11-06 2023-09-13 AATEC Medical GmbH A composition comprising extra-cellular vesicles from mesenchymal stem cells and alpha-1 antitrypsin for the treatment of viral infections
JPWO2024005157A1 (https=) * 2022-06-30 2024-01-04
CN116173218B (zh) * 2023-04-28 2023-08-04 北京大学口腔医学院 蛋白转运抑制剂在制备用于治疗或缓解牙周炎的药物中的用途
CN121909290A (zh) * 2023-07-10 2026-04-21 普瑞赛格恩公司 α-1抗胰蛋白酶缺乏症的治疗

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266491A (en) * 1989-03-14 1993-11-30 Mochida Pharmaceutical Co., Ltd. DNA fragment and expression plasmid containing the DNA fragment
US20070003518A1 (en) 2002-04-19 2007-01-04 Atkinson Mark A Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US9457070B2 (en) * 2005-06-07 2016-10-04 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
EP2578677A1 (en) 2007-08-09 2013-04-10 Genzyme Corporation Method of treating autoimmune disease with mesenchymal stem cells
US8758761B2 (en) 2007-09-30 2014-06-24 University Of Florida Research Foundation, Inc. Combination therapies for treating type 1 diabetes
EP2626369A1 (en) * 2011-11-24 2013-08-14 Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Engineered mesenchymal stem cells and their therapeutic use
BR112014014751A8 (pt) * 2011-12-19 2017-07-04 Lfb Usa Inc composição compreendendo alfa-1-antitripsina, células epiteliais de glândula mamária, mamífero não humano transgênico, e, método para reduzir a atividade de elastase no pulmão
CN102920735A (zh) 2012-11-14 2013-02-13 青岛奥克生物开发有限公司 一种间充质干细胞注射液及其制备方法和在制备治疗糖尿病药物中的应用
CN105456293A (zh) 2014-09-05 2016-04-06 深圳市北科生物科技有限公司 一种用于治疗糖尿病的干细胞制剂及其制备方法

Similar Documents

Publication Publication Date Title
JP2024010006A5 (https=)
US20080167230A1 (en) Methods and compositions for treating or preventing lesions of the respiratory epithelium
JP2018502579A5 (https=)
US20090227511A1 (en) Methods and compositions for treating lesions of the respiratory epithelium
US7973005B2 (en) Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases
CN114533706B (zh) 一种用于防治呼吸道疾病的雾化吸入制剂及其应用
EP0551077A2 (en) Pharmaceutical composition comprising atrial nutriuretic peptide for treatment of adult respiratory distress syndrome
WO2021253647A1 (zh) 小分子抑制剂在治疗呼吸道病毒性肺炎上的应用
JPWO2022096708A5 (https=)
EP4051307B1 (en) Peptide for prevention or treatment of covid-19
EP3813866B1 (en) Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
Ñamendys-Silva et al. Noninvasive ventilation in immunosuppressed patients
US20250152613A1 (en) Compositions and methods for covid-19 treatment
CN111467354A (zh) 格列齐特在制备治疗肺纤维化疾病药物中的应用
Heaney et al. Cocaine‐induced cardiomyopathy in a paediatric patient
Novak-Jankovič et al. A comparison of intravenous and inhalational maintenance anaesthesia for endoscopic procedures
Gallo et al. Use of endotracheal isoproterenol for severe bronchospasm while weaning from cardiopulmonary bypass
RU2326670C1 (ru) Способ комплексной интенсивной терапии острого стенозирующего ларинготрахеита у детей
JPWO2021138682A5 (https=)
LeVine Bronchiolitis
JPWO2023154705A5 (https=)
Rees Treatment of Acute Asthma
CN111454366A (zh) 一种融合蛋白及其应用
Janson et al. 4. ACUTE ASTHMA AND COPD EXACERBATIONS
HRP20190921T1 (hr) Genetski modificirane mezenhimske matične stanice koje ekprimiraju alfa-1 antitripsin (aat)